CMRA (Comera Life Sciences Holdings) Beginning Cash Position: $0.53 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Comera Life Sciences Holdings Beginning Cash Position?

Comera Life Sciences Holdings CMRA -99.00% Beginning Cash Position is $0.53 Mil as of Sep. 2023.

Comera Life Sciences Holdings's Beginning Cash Position for the quarter that ended in Sep. 2023 was $0.53 Mil.

Comera Life Sciences Holdings's quarterly Beginning Cash Position declined from Mar. 2023 ($2.00 Mil) to Jun. 2023 ($1.59 Mil) and declined from Jun. 2023 ($1.59 Mil) to Sep. 2023 ($0.53 Mil).

Comera Life Sciences Holdings's annual Beginning Cash Position declined from Dec. 2020 ($0.44 Mil) to Dec. 2021 ($0.18 Mil) but then increased from Dec. 2021 ($0.18 Mil) to Dec. 2022 ($6.56 Mil).

Comera Life Sciences Holdings Beginning Cash Position Related Terms

Comera Life Sciences Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Comera Life Sciences Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Comera Life Sciences Holdings Beginning Cash Position Chart

Comera Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22
Beginning Cash Position
0.44 0.18 6.56

Comera Life Sciences Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 4.99 2.72 2.00 1.59 0.53

Comera Life Sciences Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.53 Mil mean?
Comera Life Sciences Holdings (CMRA) has a Beginning Cash Position of $0.53 Mil as of Sep. 2023. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Comera Life Sciences Holdings and its competitors.
Is Comera Life Sciences Holdings' Beginning Cash Position too high?
Comera Life Sciences Holdings' current Beginning Cash Position is $0.53 Mil.
How does Comera Life Sciences Holdings' Beginning Cash Position compare to FREQ and BNTC?
Comera Life Sciences Holdings' Beginning Cash Position of $0.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Comera Life Sciences Holdings and its competitors. Comera Life Sciences Holdings's current Beginning Cash Position is $0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Comera Life Sciences Holdings stock overvalued right now?
Comera Life Sciences Holdings (CMRA) has a current Beginning Cash Position of $0.53 Mil. The current Beginning Cash Position is $0.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Comera Life Sciences Holdings (CMRA), the current Beginning Cash Position is $0.53 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Comera Life Sciences Holdings Business Description

Address 12 Gill Street, Suite 4650, Woburn, MA, USA, 01801
Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care.